FR2847472B1 - NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR THE PREVENTION OF CARDIOVASCULAR PATHOLOGIES - Google Patents

NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR THE PREVENTION OF CARDIOVASCULAR PATHOLOGIES

Info

Publication number
FR2847472B1
FR2847472B1 FR0214693A FR0214693A FR2847472B1 FR 2847472 B1 FR2847472 B1 FR 2847472B1 FR 0214693 A FR0214693 A FR 0214693A FR 0214693 A FR0214693 A FR 0214693A FR 2847472 B1 FR2847472 B1 FR 2847472B1
Authority
FR
France
Prior art keywords
prevention
pharmaceutical compositions
novel pharmaceutical
cardiovascular pathologies
pathologies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0214693A
Other languages
French (fr)
Other versions
FR2847472A1 (en
Inventor
Ludovic Predal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SYNERGIA
Original Assignee
SYNERGIA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SYNERGIA filed Critical SYNERGIA
Priority to FR0214693A priority Critical patent/FR2847472B1/en
Priority to AU2003295030A priority patent/AU2003295030A1/en
Priority to PCT/FR2003/003425 priority patent/WO2004047564A1/en
Publication of FR2847472A1 publication Critical patent/FR2847472A1/en
Application granted granted Critical
Publication of FR2847472B1 publication Critical patent/FR2847472B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6895Rescue therapy; Agonist-antagonist; Antidotes; Targeted rescue or protection, e.g. by folic acid-folinic acid or conjugated to antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0214693A 2002-11-22 2002-11-22 NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR THE PREVENTION OF CARDIOVASCULAR PATHOLOGIES Expired - Fee Related FR2847472B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0214693A FR2847472B1 (en) 2002-11-22 2002-11-22 NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR THE PREVENTION OF CARDIOVASCULAR PATHOLOGIES
AU2003295030A AU2003295030A1 (en) 2002-11-22 2003-11-19 Novel pharmaceutical compositions in particular for preventing cardiovascular pathologies
PCT/FR2003/003425 WO2004047564A1 (en) 2002-11-22 2003-11-19 Novel pharmaceutical compositions in particular for preventing cardiovascular pathologies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0214693A FR2847472B1 (en) 2002-11-22 2002-11-22 NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR THE PREVENTION OF CARDIOVASCULAR PATHOLOGIES

Publications (2)

Publication Number Publication Date
FR2847472A1 FR2847472A1 (en) 2004-05-28
FR2847472B1 true FR2847472B1 (en) 2006-08-11

Family

ID=32241541

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0214693A Expired - Fee Related FR2847472B1 (en) 2002-11-22 2002-11-22 NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR THE PREVENTION OF CARDIOVASCULAR PATHOLOGIES

Country Status (3)

Country Link
AU (1) AU2003295030A1 (en)
FR (1) FR2847472B1 (en)
WO (1) WO2004047564A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723680B1 (en) * 1994-08-19 1996-09-27 Boiron ABSORBABLE NUTRITIONAL SUPPLEMENT FOR HUMAN EVERYDAY BALANCE.
FR2723681B1 (en) * 1994-08-19 1996-09-27 Boiron ABSORBABLE NUTRITIONAL SUPPLEMENT FOR WOMEN'S DAILY BALANCE.
US6274170B1 (en) * 1999-02-18 2001-08-14 Richard Heibel Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
AU3651102A (en) * 2000-11-29 2002-06-11 Smithkline Beecham Corp Composition containing statins and calcium for improved cardiovascular health
CA2427681A1 (en) * 2000-11-29 2002-06-06 Smithkline Beecham Corporation Dietary composition containing conjugated linoleic acid and calcium for improved health
US6436431B1 (en) * 2001-07-02 2002-08-20 Diane Wright Hoffpauer Fortified rice bran food product and method for promoting cardiovascular health

Also Published As

Publication number Publication date
FR2847472A1 (en) 2004-05-28
WO2004047564A1 (en) 2004-06-10
AU2003295030A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
FR2795324B1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS
FR2775596B1 (en) NEW PHARMACEUTICAL COMPOSITIONS
FI20011478A0 (en) Pharmaceutical composition
AR028204A1 (en) ELECTRO-THREADED PHARMACEUTICAL COMPOSITIONS
HUP0400194A3 (en) Imidazolidindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them
NO20052306D0 (en) Dispersible pharmaceutical compositions.
IL162118A0 (en) Pharmaceutical compositions containing an orally active taxane derivative
ITMI20010748A0 (en) PHARMACEUTICAL COMPOSITIONS
IT1318649B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MUCOSITES AND STOMATITIS.
EE05020B1 (en) The pharmaceutical composition of G1buride
HUP0400193A3 (en) Imidazolindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them
NO20043441L (en) Orodispersible pharmaceutical composition comprising agomelatine
IL158898A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF
DK1458377T3 (en) Pharmaceutical compositions containing tegaserod
EE200300589A (en) Pharmaceutical compositions
IL209789A0 (en) Metabolites of 3-(2-dimethylaminomethyl-cyclohexyl)- phenol, pharmaceutical compositions comprising the same and uses thereof
NO20026123L (en) Pharmaceutical compositions
PT1558263E (en) PROLONGED LIBERATION PHARMACEUTICAL COMPOSITION
FR2802423B1 (en) PHARMACEUTICAL COMPOSITIONS
FI20022128A (en) Pharmaceutical composition
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
NO20031095D0 (en) Pharmaceutical compositions
FR2779145B1 (en) NEW PHARMACEUTICAL COMPOSITIONS
ITMI20022358A1 (en) EFFERVESCENT PHARMACEUTICAL COMPOSITIONS FOR THE REALIZATION OF NON-CONVENTIONAL SUSPENSIONS.
FR2847472B1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR THE PREVENTION OF CARDIOVASCULAR PATHOLOGIES

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

ST Notification of lapse

Effective date: 20220705